Patient Preference With Visicol Tablet Preparation for Colonoscopy

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of this study is to determine patient preference and acceptance of tablet sodium phosphate bowel preparation in patients who had polyethylene glycol (PEG) solution for their prior colonoscopy. This study will provide answers related to the patient preferences and their acceptance of this new method of bowel preparation.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05107505` - Evaluation of The Factors Affecting Bowel Preparation Adequacy for Colonoscopy
Completed	`NCT02661750` - Safety and Efficacy of High Dose Bowel Preparation Solutions for Patients With Difficult To Clean Colons For Colonoscopy
Completed	`NCT01063049` - Gatorade/Miralax With or Without Bisacodyl Versus NuLytely for Colonoscopy Preparation	Phase 4

NCT number	NCT00318305
Study type	Observational
Source	Mayo Clinic
Contact
Status	Completed
Phase	N/A
Start date	March 2005
Completion date	April 2006

Patient Preference With Visicol Tablet Preparation for Colonoscopy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms